$ARCB

ARCBEST CORP /TX/

Insider trades

No enriched coverage for $ARCB in the last 7 days.

$3.1M
MCREYNOLDS JUDY R
0%
See all $ARCB insider activity →
Low

Anderson Dennis L II sold $737K of ARCB

Anderson Dennis L II (Chief Innovation Officer) sold 5,450 shares of ARCBEST CORP /TX/ (ARCB) at an average of $135.16 ($134.87–$135.63, $0.74M total) across 2 trades on 2026-08-11.

Stipp Janice E sold $694K of ARCB

Stipp Janice E sold 5,000 shares of ARCBEST CORP /TX/ (ARCB) at an average of $138.71 ($137.46–$139.20, $0.69M total) across 2 trades on 2026-08-06.

ARCB sentiment & insider activity

Recent ARCB coverage spans insider activity, earnings and market movers.

In the last 30 days, ARCB insiders filed 8 SEC Form 4 transactions — no purchases and 8 sales ($3.1M). The most active reporter was MCREYNOLDS JUDY R with 3 filings.

What's driving ARCB

  • This is a routine insider sale disclosure with no stated 10b5-1 plan, but it does not provide new fundamentals or guidance.

    SEC EDGAR · Aug 12, 2026

  • This is a routine Form 4 insider sale with no 10b5-1 plan disclosed, but it does not provide new operational or financial guidance.

    SEC EDGAR · Aug 10, 2026

  • This is an insider sale, not a fundamental company disclosure, so it is more of a sentiment/positioning signal than a catalyst.

    SEC EDGAR · Aug 7, 2026

  • This is a routine insider sale disclosure with no 10b5-1 plan, but it does not by itself signal a fundamental change.

    SEC EDGAR · Aug 7, 2026

  • This is a routine insider sale with no 10b5-1 plan disclosed, but it does not provide new operational or financial information for ARCB.

    SEC EDGAR · Aug 6, 2026

alphai scores every news story that mentions ARCB with an AI model for sentiment and relevance, and aggregates insider trades from ARCBEST CORP /TX/'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ARCB

Score

ArcBest’s Q2 Earnings Call: Our Top 5 Analyst Questions

ArcBest reported Q2 revenue of $1.18B, matching analyst estimates, and adjusted EPS of $2.38 versus $2.26 expected. Adjusted EBITDA was $115M versus $111.7M. Operating margin fell to -1.7% from 3.6% a year earlier, with sales volumes down 2.8% YoY. Management cited pricing discipline, efficiency gains, and noted no broad industrial demand inflection.

$ARCBMed

ARCB Q2 Deep Dive: Restructuring and Digital Initiatives Take Center Stage Amid Market Challenges

ArcBest reported Q2 revenue of $1.18B, matching analyst estimates, with adjusted EPS of $2.38 vs $2.26 and adjusted EBITDA of $115M vs $111.7M. Operating margin fell to -1.7% from 3.6% a year earlier, and sales volumes declined 2.8% YoY. The company outlined restructuring and ArcBestView digital initiatives, targeting $40M annualized cost savings and growth in managed solutions.

$ARCBMed

ArcBest Q2 Earnings Call Highlights

The company expects the initiatives to generate about $40 million in annualized cost savings. Chief Financial Officer Matt Beasley said ArcBest recognized about $2 million of savings in the second quarter and expects approximately $6 million in the third quarter. The company expects to reach the full $10 million quarterly run rate by the first quarter of 2027. About 75% of the $40 million in savings is associated with the asset-based business.

$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.

Related tickers

ARCB — Arcbest news & insider trades | alphai